Biopharmaceutical company focused on eye care treatments
Tarsus is a publicly traded biopharmaceutical company executing a product launch while building internal operational infrastructure. The hiring mix—dominated by sales (28 roles) with minimal engineering (1 role)—reflects a commercial-stage biotech structure rather than a platform-play. Active projects span ERP implementation, lab operationalization, and managed care expansion, while pain points cluster around compliance (SOX, PDMA) and commercial execution in a complex selling environment.
Tarsus Pharmaceuticals develops and commercializes treatments in ophthalmology, operating as a public company since 2017. The company is actively launching new eye care products and scaling sales infrastructure to reach patients through managed care channels. Current operational focus includes implementing a new ERP system, operationalizing in-house laboratory facilities, and building out clinical data visualization and financial automation capabilities. The organization spans 201–500 employees headquartered in Irvine, California, with all hiring currently in the United States.
Tarsus uses NetSuite (ERP), Salesforce (CRM), Adaptive Planning and FloQast (financial planning), Tableau (analytics), ServiceNow (IT service management), and standard Microsoft Office tools. They are implementing a new ERP system as part of current operational projects.
Tarsus is in active launch and ongoing growth phase for Xdemvy, an eye care treatment. Launch performance and managed care penetration are tracked as key metrics in the commercial roadmap.
Other companies in the same industry, closest in size